{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Anita Horvatic"}, {"accession": "MS:1000589", "name": "contact email", "value": "horvatic.ani@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Zagreb, Faculty of Veterinary Medicine"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Peter David Eckersall"}, {"accession": "MS:1000589", "name": "contact email", "value": "David.Eckersall@glasgow.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "VetMedZg Laboratory,Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia    Institute of Biodiversity, Animal Health & Comparative Medicine, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, UK"}]}], "datasetFiles": [{"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_agarikon_all_PSMs.txt"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_agarikon_all_PeptideGroups.txt"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_agarikon_all_ProteinGroups.txt"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_agarikon_all_Proteins.txt"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_agarikon_ten1.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_agarikon_ten2.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_agarikon_ten3.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190611_agarikon_ten4.mgf"}, {"accession": "MS:1002851", "name": "Other type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/TMT scheme.xlsx"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_Agarikon_ten1.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_Agarikon_ten2.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190606_Agarikon_ten3.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827/20190611_Agarikon_ten4.raw"}], "description": "Colorectal cancer (CRC) is the third most frequent cancer type in both males and females, with about 35% of patients being diagnosed in stage IV metastatic disease. Despite advancements in treatment, life expectancy in patients with metastatic disease is low. Due to frequent drug resistance during conventional and targeted cancer treatments, the development and testing of multi-target therapies is an important objective. Medicinal mushrooms specific compound isolates as well as complex extract mixtures have been studied in depth, and many mushroom species have been proven to be non-toxic multi-target inhibitors of specific oncogenic pathways, as well as potent immunomodulators. In this study, we have performed a tandem mass tags qualitative and quantitative proteomic analyses of CT26.WT colon cancer tumor tissues from Balb/c mice treated with proprietary medicinal mushroom extract Agarikon.1\u00ae, with or without 5-fluorouracil.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/10/PXD018827"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD018827"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD018827"}], "instruments": [{"accession": "MS:1002634", "name": "Q Exactive Plus"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Agarikon, advanced colorectal cancer, medicinal mushroom supplement, animal model, Balb/c mice, TMT, proteomics"}], "modifications": [{"accession": "MOD:01720", "name": "TMT6plex-126 reporter+balance reagent acylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "32973493"}, {"accession": "MS:1002866", "name": "Reference", "value": "Jakopovic B, Horvati\u0107 A, Klobu\u010dar M, Gelemanovi\u0107 A, Grb\u010di\u0107 P, Or\u0161oli\u0107 N, Jakopovich I, Kraljevi\u0107 Paveli\u0107 S. Treatment With Medicinal Mushroom Extract Mixture Inhibits Translation and Reprograms Metabolism in Advanced Colorectal Cancer Animal Model as Evidenced by Tandem Mass Tags Proteomics Analysis. Front Pharmacol. 2020 11:1202"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Mus musculus (Mouse)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10090"}]}], "title": "Proteomic investigation of treatment with medicinal mushroom supplement Agarikon.1\u00ae in advanced colorectal cancer animal model"}